1. Home
  2. NRSN vs DFNS Comparison

NRSN vs DFNS Comparison

Compare NRSN & DFNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.85

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

DFNS

T3 Defense Inc. Common Stock

N/A

Current Price

$0.35

Market Cap

27.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
NRSN
DFNS
Founded
2017
2013
Country
Israel
United States
Employees
16
15
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
27.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NRSN
DFNS
Price
$0.85
$0.35
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
138.1K
1.5M
Earning Date
03-31-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$583.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.32
52 Week High
$2.60
$2.68

Technical Indicators

Market Signals
Indicator
NRSN
DFNS
Relative Strength Index (RSI) 57.00 31.99
Support Level $0.85 N/A
Resistance Level $1.06 $0.51
Average True Range (ATR) 0.07 0.05
MACD -0.00 0.01
Stochastic Oscillator 53.65 15.28

Price Performance

Historical Comparison
NRSN
DFNS

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About DFNS T3 Defense Inc. Common Stock

T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with tough customer relationships and solid order backlogs, often capacity-and resource-constrained and specialized areas such as drones and autonomous vehicles, counter-drone systems, main manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and ideas, and decentralized day-to-day operations, it aims to strengthen essential defense capabilities and build long-term value.

Share on Social Networks: